Sickle Cell Disease Diagnosis Market Size Will Reach $60.03 Million in 2023

Sickle cell disease is an inherited blood disorder that usually presents with symptoms such as chronic anemia, pain, and fatigue. Its diagnosis is usually done with a blood test, where the doctor looks at the shape and size of the red blood cells, and the amount of hemoglobin in the red blood cells. If the red blood cells are sickle-shaped or crescent-shaped, or the hemoglobin level is lower than normal, then it may be sickle cell disease. 

Sickle Cell Disease Diagnosis Market Development Analysis in Major Regions 

In terms of geographical distribution, North America and Europe are the major regions of the global sickle cell disease diagnostics market with advanced medical facilities and a highly developed biotechnology industry.  There is also a high demand for sickle cell disease diagnosis in these regions, mainly due to their high incidence and relatively well-developed social health care systems. According to our research data, the North American and European sickle cell disease market revenue is estimated to be $26.44 million and $12.53 million in 2023, respectively, and the share of the global market revenue is expected to reach 44.04% and 20.87%. 

In addition, the market potential of the Asia-Pacific region and Latin America is gradually emerging. The market for sickle cell disease diagnosis is expected to grow in the future due to the large population, rapid economic development, and increased government investment in health care in these regions.

Global Sickle Cell Disease Diagnosis Market Revenue and Share  Forecast by Region in 2023

Source: www.globalmarketmonitor.com

Global Sickle Cell Disease Diagnostics Market Development Overview and Competitive Landscape Analysis 

Since sickle cell disease is an inherited blood disorder, its diagnosis market is mainly driven by developments in the fields of genetics and hematology.  Studies have shown that the global sickle cell disease diagnosis market has shown a steady growth trend in recent years. According to our research data, the global sickle cell disease diagnosis market is expected to reach $60.03 million in 2023 and is expected to continue to grow to $68.62 million by 2025. 

From the perspective of market competition, the global sickle cell disease diagnosis market is highly concentrated. Data show that in 2020, the industry's top 3 companies in sickle cell disease diagnosis market revenue totaled $35.52 million, and the total market share reached 71.07%. The top 3 companies were Fisher Scientific, Atlas Medical, and BioMedomics Inc. In 2020, the revenue of the three companies' sickle cell disease diagnosis market will account for 49.69%, 12.19%, and 9.19% of the global market, respectively.